Product / Gastrointestinal & Hepatobiliary System / Antacids, Antirefluk Agen & Antiulcerants / LANSOPRAZOLE - Delayed Release Capsules

LANSOPRAZOLE - Delayed Release Capsules

Group

Prescription Drug

Composition

Each delayed-release capsule contains 8.5% Lansoprazole pellets equivalent to 30 mg Lansoprazole.

Packaging

10 Strips @10 Delayed release capsule

Registration No.

GKL 2434016503A1

Indication

Treatment of duodenal ulcers, benign gastric ulcers, reflux esophagitis.

Dose

Recommended dosage:
Duodenal ulcer: 30 mg once daily for 4 weeks.
Benign gastric ulcer: 30 mg once daily for 8 weeks.
Esophageal reflux: 30 mg once daily for 4 weeks.